116 related articles for article (PubMed ID: 351232)
1. Nitrate therapy for congestive heart failure.
Franciosa JA; Nordstrom LA; Cohn JN
JAMA; 1978 Aug; 240(5):443-6. PubMed ID: 351232
[TBL] [Abstract][Full Text] [Related]
2. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study.
Cohn JN; Archibald DG; Ziesche S; Franciosa JA; Harston WE; Tristani FE; Dunkman WB; Jacobs W; Francis GS; Flohr KH
N Engl J Med; 1986 Jun; 314(24):1547-52. PubMed ID: 3520315
[TBL] [Abstract][Full Text] [Related]
3. Improved exercise capacity and differing arterial and venous tolerance during chronic isosorbide dinitrate therapy for congestive heart failure.
Leier CV; Huss P; Magorien RD; Unverferth DV
Circulation; 1983 Apr; 67(4):817-22. PubMed ID: 6337742
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamic assessment of oral peripheral vasodilator therapy in chronic congestive heart failure: prolonged effectiveness of isosorbide dinitrate.
Williams DO; Bommer WJ; Miller RR; Amsterdam EA; Mason DT
Am J Cardiol; 1977 Jan; 39(1):84-90. PubMed ID: 318795
[TBL] [Abstract][Full Text] [Related]
5. A comparison between the effects of diltiazem and isosorbide dinitrate on digoxin pharmacodynamics and kinetics in the treatment of patients with chronic ischemic heart failure.
Mahgoub AA; El-Medany AH; Abdulatif AS
Saudi Med J; 2002 Jun; 23(6):725-31. PubMed ID: 12070557
[TBL] [Abstract][Full Text] [Related]
6. Effect of enalapril, hydralazine plus isosorbide dinitrate, and prazosin on hospitalization in patients with chronic congestive heart failure. The V-HeFT VA Cooperative Studies Group.
Loeb HS; Johnson G; Henrick A; Smith R; Wilson J; Cremo R; Cohn JN
Circulation; 1993 Jun; 87(6 Suppl):VI78-87. PubMed ID: 8500244
[TBL] [Abstract][Full Text] [Related]
7. Hemodynamic effects of orally administered isosorbide dinitrate in patients with congestive heart failure.
Franciosa JA; Mikulic E; Cohn JN; Jose E; Fabie A
Circulation; 1974 Nov; 50(5):1020-4. PubMed ID: 4609633
[No Abstract] [Full Text] [Related]
8. Hydralazine and isosorbide dinitrate combination improves exercise tolerance in heart failure. Results from V-HeFT I and V-HeFT II. The V-HeFT VA Cooperative Studies Group.
Ziesche S; Cobb FR; Cohn JN; Johnson G; Tristani F
Circulation; 1993 Jun; 87(6 Suppl):VI56-64. PubMed ID: 8500241
[TBL] [Abstract][Full Text] [Related]
9. Improvement in exercise haemodynamics by isosorbide dinitrate in patients with severe congestive cardiac failure secondary to ischaemic heart disease.
Stephens J; Camm J; Spurrell R
Br Heart J; 1978 Aug; 40(8):832-7. PubMed ID: 687484
[TBL] [Abstract][Full Text] [Related]
10. Effect of isosorbide dinitrate on response to submaximal and maximal exercise in patients with congestive heart failure.
Franciosa JA; Cohn JN
Am J Cardiol; 1979 May; 43(5):1009-14. PubMed ID: 433762
[TBL] [Abstract][Full Text] [Related]
11. [Vasodilator therapy in congestive heart failure--hemodynamic effects of oral administered isosorbide dinitrate (author's transl)].
Osamura Y; Takahashi S; Nakai K; Kimata S; Ogawa T; Hirosawa K
Kokyu To Junkan; 1978 Jul; 26(7):677-83. PubMed ID: 674893
[No Abstract] [Full Text] [Related]
12. Veterans Administration Cooperative Study on Vasodilator Therapy of Heart Failure: influence of prerandomization variables on the reduction of mortality by treatment with hydralazine and isosorbide dinitrate.
Cohn JN; Archibald DG; Francis GS; Ziesche S; Franciosa JA; Harston WE; Tristani FE; Dunkman WB; Jacobs W; Flohr KH
Circulation; 1987 May; 75(5 Pt 2):IV49-54. PubMed ID: 3552302
[TBL] [Abstract][Full Text] [Related]
13. Comparative hemodynamic effects of chewable isosorbide dinitrate and nitroglycerin in patients with congestive heart failure.
Mikulic E; Franciosa JA; Cohn JN
Circulation; 1975 Sep; 52(3):477-82. PubMed ID: 808359
[TBL] [Abstract][Full Text] [Related]
14. Plasma norepinephrine, plasma renin activity, and congestive heart failure. Relations to survival and the effects of therapy in V-HeFT II. The V-HeFT VA Cooperative Studies Group.
Francis GS; Cohn JN; Johnson G; Rector TS; Goldman S; Simon A
Circulation; 1993 Jun; 87(6 Suppl):VI40-8. PubMed ID: 8500238
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the hemodynamic responses to molsidomine and isosorbide dinitrate in congestive heart failure.
Unger P; Vachiery JL; de Cannière D; Staroukine M; Berkenboom G
Am Heart J; 1994 Sep; 128(3):557-63. PubMed ID: 8074020
[TBL] [Abstract][Full Text] [Related]
16. Haemodynamic effects of isosorbide dinitrate in patients with congestive cardiac failure at rest and during submaximal supine exercise.
Stephens JD; Camm AJ; Spurrell RA
Arch Mal Coeur Vaiss; 1978 Mar; 71(3):241-50. PubMed ID: 416797
[TBL] [Abstract][Full Text] [Related]
17. Haemodynamic effects of oral salbutamol alone and in combination with sublingual isosorbide dinitrate in patients with severe congestive cardiac failure.
Stephens JD; Banim SO; Spurrell RA
Br Heart J; 1980 Feb; 43(2):220-5. PubMed ID: 7362716
[TBL] [Abstract][Full Text] [Related]
18. Effect of isosorbide dinitrate on submaximal exercise capacity of patients with chronic left ventricular failure.
Wilson JR; Ferraro N
Chest; 1982 Dec; 82(6):701-4. PubMed ID: 7140397
[TBL] [Abstract][Full Text] [Related]
19. Comparative haemodynamic and peripheral vasodilator effects of oral and chewable isosorbide dinitrate in patients with refractory congestive cardiac failure.
Figueras J; Taylor WR; Ogawa T; Forrester JS; Singh BN; Swan HJ
Br Heart J; 1979 Mar; 41(3):317-24. PubMed ID: 371647
[No Abstract] [Full Text] [Related]
20. [The long-acting effects of isosorbide dinitrate on left ventricular performance in congestive heart insufficiency. Phonocardiographic study].
Barretto AC; Savioli RM; Lima EV; Martinelli Filho M; Mady C; Del Nero E
Arq Bras Cardiol; 1980 Jan; 34(1):67-71. PubMed ID: 7406740
[No Abstract] [Full Text] [Related]
[Next] [New Search]
